News | November 25, 2008

ANS Plus RT for Breast Cancer Lowers Morbidity

November 25, 2008 - Techniques such as axillary node sampling (ANS) and, more recently, sentinel node biopsy, in combination with radiotherapy (RT) have the potential to reduce toxicity for patients with early-stage breast cancer.

Since axillary treatment for patients with early-stage breast cancer can be associated with considerable morbidity, the study aimed to assess the outcome and morbidity of ANS in combination with radiotherapy. Researchers conducted a retrospective review of axillary treatment in patients with early stage breast cancer treated at the The Cancer Centre, University Hospital Birmingham, Queen Elizabeth Medical Centre, Birmingham, UK, between 1997 and 2003.

The treatment policy was to carry out four-node, Edinburgh-style ANS except in those cases with either palpably enlarged nodes or cytological confirmation of involvement or with clinically obvious node involvement at surgery when level 2 axillary node clearance (ANC) was carried out. Patients with involved nodes after ANS received postoperative axillary radiotherapy.

In total, 381 patients were included, 331 received ANS and 50 received ANC. The median follow-up was 6.5 years and overall survival at 5 years was 84 percent. Pathologically involved nodes were found in 152/331 (50 percent) ANS patients and 43/50 (86 percent) ANC patients. The rate of local recurrence (breast or chest wall) at 5 years was 4 percent (95 percent confidence interval 1-17 percent) in the ANC group and 2 percent (95 percent confidence interval 1-4 percent) in the ANS group. The nodal recurrence rate of those undergoing ANS was 3 percent (11/331) compared with 6 percent (3/50) for those treated by ANC. The rate of clinically significant lymphoedema at 5 years was significantly higher (P=0.01) in the ANC arm: 18 percent (95 percent confidence interval 9-32 percent) compared with 5 percent (95 percent confidence interval 3-8 percent) in those treated by ANS. Thirty-one cases received additional supraclavicular fossa irradiation because of the involvement of more than four nodes on ANS, which may not have been available with sentinel node biopsy and has implications for current practice.

The researchers concluded that selective ANS with the removal of a minimum of four nodes guides optimal locoregional treatment with good local control rates, low overall morbidity and may obviate the need for a second surgical procedure.

Source: doi:10.1016/j.clon.2008.06.006

Related Content

MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
News | Image Guided Radiation Therapy (IGRT) | July 31, 2017
Elekta’s magnetic resonance radiation therapy (MR/RT) system will be the subject of 21 abstracts at the 59th American...
Accuray Receives 510(k) Clearance for iDMS Data Management System
Technology | Oncology Information Management Systems (OIMS) | July 31, 2017
July 31, 2017 — Accuray Inc. announced it has received 510(k) clearance from the U.S.
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Overlay Init